Successful management of a case of primary cutaneous mucormycosis in an immunocompetent host.
Primary cutaneous mucormycosis is a rare disease in the immunocompetent, and research on this condition is limited to case reports. Clinical presentation is not sufficiently distinctive to allow a diagnosis and the immunocompetent state precludes even the suspicion of the condition. There is agreement in literature regarding the absence of guidelines for its treatment. Most reports have used a combination of aggressive and repeated surgical debridement and systemic antifungals, usually amphotericin B. The authors propose the use of vacuumassisted closure technology in managing these wounds with a possible role in decreasing the number and extent of debridement and limiting deeper tissue damage. ﻿﻿﻿.